Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuronetics (STIM) Equity Ratio (2017 - 2026)

Neuronetics has reported Equity Ratio over the past 10 years, most recently at 0.11 for Q1 2026.

  • Quarterly Equity Ratio fell 62.02% to 0.11 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.11 through Mar 2026, down 62.02% year-over-year, with the annual reading at 0.19 for FY2025, 17.86% down from the prior year.
  • Equity Ratio was 0.11 for Q1 2026 at Neuronetics, down from 0.19 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.59 in Q1 2022 and troughed at 0.11 in Q1 2026.
  • The 5-year median for Equity Ratio is 0.28 (2025), against an average of 0.33.
  • Year-over-year, Equity Ratio crashed 68.98% in 2024 and then skyrocketed 48.58% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.49 in 2022, then plummeted by 39.54% to 0.3 in 2023, then decreased by 23.54% to 0.23 in 2024, then decreased by 17.86% to 0.19 in 2025, then crashed by 42.95% to 0.11 in 2026.
  • Per Business Quant, the three most recent readings for STIM's Equity Ratio are 0.11 (Q1 2026), 0.19 (Q4 2025), and 0.19 (Q3 2025).